If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKonami Grp Corp Regulatory News (KNM)

Share Price Information for Konami Grp Corp (KNM)

Share Price is delayed by 15 minutes
Get Live Data
18,364.34162    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap:
KNM Live PriceLast checked at - London Stock Exchange

Intraday Konami Grp Corp Share Chart

Delisting ADSs from NYSE Became Effective

27 Apr 2015 09:24

RNS Number : 3867L
Konami Corporation
27 April 2015
 



April 27, 2015

FOR IMMEDIATE RELEASE

 

KONAMI CORPORATION

Takuya Kozuki, Representative Director, President

Shares listed: Tokyo and London Stock Exchange

 

Contact: Junichi Motobayashi, General Manager, Finance and Accounting

 Tel: +81-3-5771-0222

 

Notice on Delisting American Depositary Shares

from New York Stock Exchange Became Effective

KONAMI CORPORATION (the "Company") hereby announces that the voluntary delisting of its American Depositary Shares ("ADSs") from the New York Stock Exchange (the "NYSE") became effective prior to the opening of trading on April 24, 2015 (Eastern Time in the U.S.) as scheduled, following the filing, on April 13, 2015, of a Form 25 with the U.S. Securities and Exchange Commission (the "SEC") for delisting from the NYSE and deregistration with the SEC as announced on April 1, 2015. In addition, the Company has filed a Form 15F with the SEC on April 24, 2015 to terminate its reporting obligations under the U.S. Securities Exchange Act of 1934, as amended (the "Exchange Act").

 

1. Effective Date of Delisting(Eastern Time in the U.S.)

April 24, 2015

 

2. Stock Exchanges on which the Company Maintains its Listings 

The Tokyo Stock Exchange and the London Stock Exchange

3. Deregistration with the SEC

The deregistration will become effective on July 12, 2015, 90 days after the filing of Form 25 with the SEC. The Company's reporting obligations under the Exchange Act were suspended by the filing of Form 15F with the SEC and will be terminated on July 23, 2015, 90 days after its filling.

Note: The schedule provided above, including the anticipated effective dates, may be delayed if the SEC objects or requests an extended review or for other reasons.

4. Future Plans 

After the delisting of its ADSs from the NYSE, the Company maintains its American Depositary Receipt Program in the U.S., and therefore its ADSs continue to be traded in the U.S. on the over-the-counter market.

While the Company's reporting obligations under the Exchange Act (including the obligation to file annual reports on Form 20-F) will be terminated, the Company will continue to disclose financial statements and other information, in English, on its website to ensure that its overseas shareholders and investors will continue to have appropriate information about the Company.

 

5. Contact Information for Inquiries regarding the Company's ADSs 

JPMorgan Service Center (U.S.)

Tel:

U.S.: 800-990-1135 (toll free)

International: +1- 651-453-2128

Website:

www.adr.com

E-mail:

jpmorgan.adr@wellsfargo.com

Shareholder Service Representatives are available Monday through Friday, from 7:00 a.m. to 7:00 p.m. Eastern Time in the U.S.

 

 

Cautionary Statement with Respect to Forward-Looking Statements:

Statements made in this document with respect to our current plans, estimates, strategies and beliefs, including the above forecasts, are forward-looking statements about our future performance. These statements are based on management's assumptions and beliefs in light of information currently available to it and, therefore, you should not place undue reliance on them. A number of important factors could cause actual results to be materially different from and worse than those discussed in forward-looking statements. Such factors include, but are not limited to: (i) changes in economic conditions affecting our operations; (ii) fluctuations in currency exchange rates, particularly with respect to the value of the Japanese yen, the U.S. dollar and the Euro; (iii) our ability to continue to win acceptance of our products, which are offered in highly competitive markets characterized by the continuous introduction of new products, rapid developments in technology and subjective and changing consumer preferences; (iv) the timing of the release of new game titles and products, especially game titles and products that are part of historically popular series; (v) our ability to successfully expand internationally with a focus on our Digital Entertainment business and Gaming & Systems business; (vi) our ability to successfully expand the scope of our business and broaden our customer base through our Health & Fitness business; (vii) regulatory developments and changes and our ability to respond and adapt to those changes; (viii) our expectations with regard to further acquisitions and the integration of any companies we may acquire; and (ix) the outcome of existing contingencies.

 

 

End of File

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCPKODBFBKKDQB
Date   Source Headline
26th Jun 20267:41 amRNSRelease: Policy on Reduction of Stock Trading Unit
8th May 20269:54 amRNSRelease: Change of Representative Directors
8th May 20269:52 amRNS4th Quarter Results
8th May 20269:52 amRNSRelease: Distribution of Retained Earnings
19th Feb 20268:22 amRNSAbsorption-Type Merger of Konami Real Estate
29th Jan 20267:15 amRNSRevision Consolidated/Dividend Forecast 03.2026
29th Jan 20267:13 amRNS3rd Quarter Results
13th Nov 20257:08 amRNSNotice of Half Securities Report filed with LFB
30th Oct 20257:14 amRNSHalf-year Report
31st Jul 202510:09 amRNS1st Quarter Results
28th Jul 20257:14 amRNSAnnual Financial Report
27th Jun 20257:39 amRNSRelease: Policy on Reduction of Stock Trading Unit
15th May 20257:13 amRNSNotice: Business Reorganization
8th May 20258:44 amRNS4th Quarter Results
8th May 20258:44 amRNSRelease: Candidates as Director
8th May 20258:43 amRNSRelease: Distribution of Retained Earnings
31st Jan 20257:27 amRNSRevision Consolidated/Dividend Forecast 03.2025
31st Jan 20257:24 amRNS3rd Quarter Results
13th Nov 20247:00 amRNSNotice of Half Securities Report filed with LFB
31st Oct 20247:00 amRNS2nd Quarter Results
1st Aug 20248:10 amRNS1st Quarter Results
25th Jul 20247:00 amRNSAnnual Financial Report
27th Jun 20247:43 amRNSRelease: Policy on Reduction of Stock Trading Unit
9th May 20247:49 amRNSRelease: Candidates as Director
9th May 20247:48 amRNSRelease: Distribution of Retained Earnings
9th May 20247:46 amRNS4th Quarter Results
1st Feb 20247:50 amRNSRelease: Revision of the Consolidated Forecast
1st Feb 20247:49 amRNS3rd Quarter Results
13th Nov 20237:00 amRNSNotice of Qtly Securities Report filed with TSE
2nd Nov 20237:41 amRNS2nd Quarter Results
3rd Aug 20238:14 amRNS1st Quarter Results
25th Jul 20238:21 amRNSAnnual Financial Report
29th Jun 20237:47 amRNSView and Policy on Reduction of Stock Trading Unit
11th May 202310:15 amRNSCandidates for Appointment as Director
11th May 202310:13 amRNS4th Quarter Results
2nd Feb 20237:26 amRNSRevision of the Consolidated Earnings Forecast
2nd Feb 20237:23 amRNS3rd Quarter Results
11th Nov 20227:00 amRNSNotice of Qtly Securities Report filed with TSE
2nd Nov 20229:08 amRNS2nd Quarter Results
4th Aug 202210:18 amRNS1st Quarter Results
26th Jul 20228:34 amRNSAnnual Financial Report
29th Jun 20227:39 amRNSView and Policy on Reduction of Stock Trading Unit
19th May 20227:52 amRNSAdjustment of Conversion Price for Zero Coupon CB
12th May 20228:21 amRNSAmendments to the Articles of Incorporation
12th May 20228:20 amRNSDifference between Results for FY22 & FY21
12th May 20228:20 amRNSDistribution of retained earnings
12th May 20228:20 amRNS4th Quarter Results
21st Apr 20228:10 amRNSNotice on Change of Company's Trade Name
3rd Feb 20228:14 amRNS3rd Quarter Results
18th Nov 20217:00 amRNSApplication for Selection of Prime Market of TSE

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.